drugset / Trial / NCT04823208

A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)

NCT04823208

Phase 1 Completed 64 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindBasic science

Summary

The main purpose of this study is to learn about the side effects of LY3437943 when given to Japanese participants with type 2 diabetes mellitus. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. Each enrolled participant will receive injections of LY3437943 or placebo given just under the skin. For each participant, the study will last up to 5 months, inclusive of screening and will include 16 visits to the study center.

Timeline

Start
2021-05-24
Primary completion
2022-06-23
Completion
2022-06-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Retatrutide Protein / enzyme biologic Subcutaneous